Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2

The novel coronavirus (SARS-CoV-2) outbreak has started taking away the millions of lives worldwide. Identification of known and approved drugs against novel coronavirus disease (COVID-19) seems to be an urgent need for the repurposing of the existing drugs. So, here we examined a safe strategy of u...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Pharm Sci
Main Authors: Peele, K.Abraham, Kumar, Vikas, Parate, Shraddha, Srirama, Krupanidhi, Lee, Keun Woo, Venkateswarulu, T.C.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Pharmacists Association®. Published by Elsevier Inc. 2021
נושאים:
Rapid Communication
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7934671/
https://ncbi.nlm.nih.gov/pubmed/33684397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2021.03.004
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים